Morphic Therapeutic Garners $51,500,000 Series A Funding

  • Feed Type
  • Date
  • Company Name
    Morphic Therapeutic
  • Mailing Address
    35 Gatehouse Dr. Waltham, MA 02451 USA
  • Company Description
    Morphic Therapeutics Inc. is engaged in the discovery and development of small molecules to block transmembrane integrin receptors, which play a role in several diseases.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    The company will use the proceeds to develop its candidate pipeline of oral integrin therapies for wide range of diseases
  • M&A Terms
  • Venture Investor
    SR One
  • Venture Investor
    Pfizer Venture Investments
  • Venture Investor
    Omega Funds
  • Venture Investor
    AbbVie Biotech Ventures
  • Venture Investor
    Polaris Partners

Trending on Xconomy